PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 1, 1986Proceedings of the National Academy of Sciences87 citations

In vivo evidence that cGMP is the second messenger for atrial natriuretic factor.

CHChou‐Long HuangHIHarlan E. IvesMCMartin G. Cogan

Key Result

Atrial natriuretic factor increased glomerular filtration rate by 45% and induced a >5-fold increase in Bowman's space cGMP concentration, indicating cGMP is its second messenger in vivo.

Structured PICO

P
Population
In vivo model (species not specified in abstract) for studying renal hemodynamic action
I
Intervention
Administration of atrial natriuretic factor (ANF) and intrarenal arterial infusion of dibutyryl cGMP (10 to 1000 microM)
C
Comparator
Controls (for ANF) and dibutyryl cAMP (for dibutyryl cGMP)
O
Outcome
Glomerular filtration rate (GFR) and cGMP concentration in systemic artery, renal vein, urine, Bowman's space, and end-proximal tubulesurrogate

The study demonstrates in vivo that ANF markedly stimulates glomerular production of cGMP, which acts as the second messenger mediating its effect of increasing glomerular filtration rate.

Main Result

Absolute Event Rate: 1.6% vs 1.1%

p-value: p=<0.005

Limitations

  • Extracellular application of cGMP analog should be interpreted cautiously due to limited understanding of physiological cellular concentration.
  • The 0.1-1 mM Bt2cGMP concentrations used may be unphysiological.
  • Lack of explicit examination of endothelial cells as a source of cGMP production.

Abstract

cGMP generation has been associated with many of the vascular and endocrine actions of atrial natriuretic factor (ANF) in vitro. To examine the role of cGMP as a second messenger for the renal hemodynamic action of ANF in vivo, we measured glomerular filtration rate (GFR) and cGMP concentration in systemic artery, renal vein, and urine as well as in Bowman's space and end-proximal tubule (by free-flow micropuncture) after administration of ANF. ANF increased GFR by 45% and simultaneously induced a greater than 5-fold increase of cGMP concentration in glomerular ultrafiltrate (Bowman's space) when compared to controls. There was no significant increase in either systemic artery or renal vein cGMP concentration. Thus, the source of increased Bowman's space cGMP is not from the blood via filtration but rather from either glomerular mesangial or epithelial cells, which are not in direct contact with the circulation. Although a small amount of tubular handling of cGMP occurred along the length of the nephron, the augmented cGMP production from the glomerulus accounted for most of the 10- to 12-fold higher urinary cGMP excretion observed after ANF administration. Intrarenal arterial infusion of dibutyryl cGMP, but not dibutyryl cAMP, increased GFR in a dose-dependent fashion (from 10 to 1000 microM) by a mechanism similar to that of ANF--an increase in glomerular hydraulic pressure. Thus, ANF markedly stimulated glomerular production of cGMP, which coincided with a marked increase in GFR. Since dibutyryl cGMP itself was capable of increasing GFR, cGMP is the likely second messenger for ANF in vivo.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Huang et al. (1986) studied Normal physiology (animal model) (n=29). Atrial natriuretic factor (ANF) vs. Control period (baseline) was evaluated on Glomerular filtration rate (GFR) (p=<0.005). Atrial natriuretic factor increased glomerular filtration rate by 45% and induced a >5-fold increase in Bowman's space cGMP concentration, indicating cGMP is its second messenger in vivo.

synapsesocial.com/papers/6a0fab722badbc352afe84f6https://doi.org/10.1073/pnas.83.20.8015
Ask AI
Helpful
Bookmark
Share
View Full Paper